danazol has been researched along with incb-018424 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aylı, M; Cengiz Seval, G; Özcan, M | 1 |
Camoriano, J; Dueck, A; Gano, K; Gowin, K; Hoffman, R; Kosiorek, H; Mascarenhas, J; Mesa, R; Palmer, J; Reeder, C; Tibes, R | 1 |
Björkholm, M; He, J; Liwing, J; Löfgren, C; Schain, F; Song, C; Vago, E | 1 |
Chen, J; Gale, RP; Li, B; Pan, L; Qin, T; Qu, S; Wu, J; Xiao, Z; Xu, Z; Yan, X; Zhang, P; Zhang, Y | 1 |
2 trial(s) available for danazol and incb-018424
Article | Year |
---|---|
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.
Topics: Adult; Aged; Anemia; Danazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thrombocytopenia; Treatment Outcome | 2017 |
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway.
Topics: Aged; Busulfan; Danazol; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxyurea; Lenalidomide; Male; Middle Aged; Nitriles; Norway; Pregnancy; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Registries; Survival Rate; Sweden | 2019 |
2 other study(ies) available for danazol and incb-018424
Article | Year |
---|---|
Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report.
Topics: Aged; Aspergillosis; Blood Transfusion; Danazol; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hydroxyurea; Janus Kinase 2; Lenalidomide; Leukemia, Myeloid, Acute; Male; Nitriles; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Splenectomy; Splenic Infarction; Thalidomide | 2015 |
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Thalidomide; Thrombocytopenia; Transaminases; Treatment Outcome | 2022 |